Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Brenton Taylor Biography and Net Worth

EVP of Inogen

Brenton Taylor is Executive Vice President - Engineering of Inogen, Inc. Previously, Mr. Myers is a co-founder of Inogen and has served as our Executive Vice President, Engineering since March 2014. Prior to serving in this position, Mr. Taylor served as our Vice President, Engineering from 2008 until March 2014 and as the Director of Technology with our company from 2003 to 2008. Mr. Taylor is listed as an inventor on 29 of the Company’s issued U.S. patents related to portable oxygen concentrator development. Mr. Taylor received a Bachelor of Science degree in Microbiology from the University of California, Santa Barbara.

What is Brenton Taylor's net worth?: The estimated net worth of Brenton Taylor is at least $600,728.70 as of April 15th, 2021. Mr. Taylor owns 59,774 shares of Inogen stock worth more than $600,729 as of November 16th. This net worth evaluation does not reflect any other investments that Mr. Taylor may own. Learn More about Brenton Taylor's net worth.
How do I contact Brenton Taylor?: The corporate mailing address for Mr. Taylor and other Inogen executives is 326 BOLLAY DRIVE, GOLETA CA, 93117. Inogen can also be reached via phone at (805) 562-0500 and via email at [email protected]. Learn More on Brenton Taylor's contact information.
Has Brenton Taylor been buying or selling shares of Inogen?: Brenton Taylor has not been actively trading shares of Inogen during the last ninety days. Most recently, Brenton Taylor sold 7,942 shares of the business's stock in a transaction on Tuesday, July 27th. The shares were sold at an average price of $75.02, for a transaction totalling $595,808.84. Learn More on Brenton Taylor's trading history.
Who are Inogen's active insiders?: Inogen's insider roster includes Alison Bauerlein (CFO), Raymond Huggenberger (Director), Byron Myers (EVP), and Brenton Taylor (EVP). Learn More on Inogen's active insiders.
Are insiders buying or selling shares of Inogen?: In the last year, insiders at the medical technology company sold shares 1 times. They sold a total of 10,000 shares worth more than $85,600.00. The most recent insider tranaction occured on May, 10th when EVP Jason Somer sold 10,000 shares worth more than $85,600.00. Insiders at Inogen own 1.0% of the company. Learn More about insider trades at Inogen.
Information on this page was last updated on 5/10/2024.

Brenton Taylor Insider Trading History at Inogen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/27/2021	Sell	7,942	$75.02	$595,808.84
4/15/2021	Sell	2,841	$65.21	$185,261.61	59,774
4/13/2021	Sell	1,838	$60.00	$110,280.00	58,771
3/17/2021	Sell	14,765	$51.63	$762,316.95	71,698
3/3/2021	Sell	14,765	$48.04	$709,310.60
1/26/2021	Sell	7,942	$50.02	$397,258.84	64,534
1/8/2021	Sell	11,017	$46.72	$514,714.24	67,609
10/1/2018	Sell	5,000	$244.77	$1,223,850.00	41,297
9/4/2018	Sell	5,000	$259.42	$1,297,100.00
8/1/2018	Sell	5,000	$197.80	$989,000.00	41,576
7/2/2018	Sell	5,000	$184.40	$922,000.00	41,576
6/1/2018	Sell	5,000	$183.10	$915,500.00	41,576
2/21/2018	Sell	5,000	$130.76	$653,800.00	38,982
2/16/2018	Sell	5,000	$125.06	$625,300.00	38,982
2/14/2018	Sell	15,000	$117.47	$1,762,050.00	38,982
2/28/2017	Sell	3,750	$70.07	$262,762.50	31,851
1/10/2017	Sell	5,105	$65.31	$333,407.55	31,851
1/3/2017	Sell	31,823	$65.69	$2,090,452.87	63,674
4/13/2016	Sell	6,500	$48.00	$312,000.00	31,851
10/26/2015	Sell	5,000	$41.38	$206,900.00	43,351
9/25/2015	Sell	3,333	$53.48	$178,248.84	43,351
8/25/2015	Sell	3,333	$46.84	$156,117.72	46,684
2/25/2015	Sell	15,687	$33.87	$531,318.69
1/26/2015	Sell	15,687	$31.53	$494,611.11
11/25/2014	Sell	15,687	$24.71	$387,625.77
10/27/2014	Sell	15,687	$21.67	$339,937.29

Brenton Taylor Buying and Selling Activity at Inogen

Inogen Company Overview

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Today's Range

Now: $10.05

$9.70

$10.08

50 Day Range

MA: $9.82

$8.69

$11.56

2 Week Range

Now: $10.05

$4.93

$13.33

Volume

171,150 shs

Average Volume

333,613 shs

Market Capitalization

$239.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

From Golden Crest | Ad

Click Here For Your Free Guide